谢长生基于“血不利则为水”辨治乳腺癌相关淋巴水肿经验介绍
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R730.6;R249

基金项目:


Experience Introduction of XIE Changsheng in Differentiating and Treating Breast Cancer- Related Lymphedema Based on Theory of“Blocked Blood Circulation Resulting in Water Retention”
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    介绍谢长生教授辨治乳腺癌相关淋巴水肿的临床经验。谢长生教授基于“血不利则为水”理论,从津血同源出发,认为“血不利”乃乳腺癌相关淋巴水肿的中间环节,皆因脾虚气少,血停生瘀,瘀血化水,泛溢肌表而发为肿胀。故以益气活血、利水消肿为治疗大法,诸法有:益气补虚,以脾为要;活血化瘀,去菀陈莝;调畅三焦,利水消肿;清解余毒,邪去正安。总之,重视补益脾气,达到气行血行,血行水行,肿胀自消的治疗目的。

    Abstract:

    Abstract:This paper introduces Prof. XIE Changsheng's clinical experience in differentiating and treating breast cancerrelated lymphedema. Starting from the principle that fluids and blood are from the same source and based on the theory of "blocked blood circulation resulting in water retention",Prof. XIE Changsheng believes that "blocked blood circulation" is the intermediate link of breast cancer- related lymphedema. The disease occurs because spleen and qi are deficient, and the blood stagnates so stasis is generated;and the static blood retains and generates fluid retention which overflows to the skin surface and leads to the symtom of swelling. Therefore,boosting qi and invigorating blood,and inducing diuresis to alleviate edema are the main treatment methods. The specific methods are boosting qi and supplementing deficiency, and taking spleen as the key;invigorating blood and dissolving stasis , and dissipating old hydro-stagnation ; harmonizing the triple energizers , and inducing diuresis to alleviate edema; clearing and relieving residual poison, and dispelling pathogen to protect healthy qi. In short, the emphasis on supplementing and boosting the spleen and qi can achieve the therapeutic purpose to eliminate the swelling by the normal qi flow,blood circulation and water transportation.

    参考文献
    相似文献
    引证文献
引用本文

李思佳,蔡慧君,陈飘逸,指导:谢长生.谢长生基于“血不利则为水”辨治乳腺癌相关淋巴水肿经验介绍[J].新中医,2022,54(8):162-165

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-24
  • 出版日期: